A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: Impact of HIV status on outcome

Archives of Disease in Childhood

Volumn 99, Issue 3, 2014, Pages 262-266

  Dimitriades, Konstantinos ^a,b   Morrow, Brenda May ^b   Jeena, Prakash ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; HIV; MULTIDRUG RESISTANT GRAM NEGATIVE BACTERIA; OUTCOME;

ANTI-BACTERIAL AGENTS; CHILD MORTALITY; CHILD, PRESCHOOL; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 84894049416     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304540     Document Type: Article

References (28)

1. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008;62(Suppl 1):i1-9.
2. Li J, Nation R, Milne R, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005;25: 11-25.
3. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006;55: 1619-29.
4. Tamma PD, Lee CK. Use of colistin in children. Pediatr Infect Dis J 2009;28: 534-5.
5. Iosifidis E, Antachopoulos C, Ioannidou M, et al. Colistin administration to pediatric and neonatal patients. Eur J Pediatr 2010;169: 867-74.
6. Celebi S, Hacimustafaoglu M, Koksal N, et al. Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients. Pediatr Int 2009;52: 410-14.
7. Jajoo M, Kumar V, Jain M, et al. Intravenous colistin administration in neonates. Pediatric Infect Dis J 2011;30: 218-21.
8. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012;55: 943-50.
9. Kofteridis DP, Alexopoulou C, Valachis A, et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 2010;51: 1238-44.
10. Korbila P, Michalopoulos A, Rafailidis PI, et al. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect 2010;16: 1230-6.
11. Michalopoulos AS, Tsiodras S, Rellos K, et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005;11: 115-21.
12. Falagas ME, Rizos M, Bliziotis IA, et al. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005;5:1.
13. Zylberberg H, Vargaftig J, Barbieux C, et al. Prolonged efficiency of secondary prophylaxis with colistin aerosols for respiratory infection due to pseudomonas aeruginosa in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23: 641-3.
14. Arrizabalaga Aguirreazaldegui J, Horcajada Gallego JP, Mentxaka Ugalde B, et al. Respiratory infection caused by Pseudomonas aeruginosa in patients with HIV infection. Rev Clin Esp 1996;196: 678-83.
15. Dhada B, Chhagan M, Kauchali S. Saving children 2006: a survey of child healthcare in South Africa. In: Saving children. Stephen CR, Patrick ME, eds. Pretoria: University of Pretoria, 2008: 119-27.
16. Jeena PM. Challenges in the provision of ICU services to HIV infected children in resource poor settings: a South African case study. J Med Ethics 2005;31: 226-30.
17. Morrow BM, Argent AC. Ventilator-associated pneumonia in a paediatric intensive care unit in a developing country with high HIV prevalence. J of Paediatr Child Health 2009;45: 104-11.
18. Stroud L, Srivastava P, Culver D, et al. Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). Infect Control Hosp Epidemiol 1997;18: 479-85.
19. Lo-Ten-Foe JR, de Smet AMGA, Diederen BMW, et al. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant enterobacter cloacae and acinetobacter baumannii strains. Antimicrob Agents Chemother 2007;51: 3726-30.
20. Slogrove ABR, Naidoo S, De Beer C, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012;58: 505-8.
21. Gounden R, Bamford C, van Zyl-Smit R, et al. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect Dis 2009;9:26.
22. Rosanova M, Epelbaum C, Noman A, et al. Use of colistin in a pediatric burn unit in argentina. J Burn Care Res 2009;30: 612-15.
23. Falagas ME, Sideri G, Vouloumanou EK, et al. Intravenous colistimethate (Colistin) use in critically ill children without cystic fibrosis. Pediatr Infect Dis J 2009;28: 123-7.
24. Jesse A, Sussan C, Ellenberg SS. Adverse event detection in drug development: reccomendations and obligations beyond Phase 3. Am J Public Health 2008;98: 1366-71.
25. Gauvin FCD, Chaibou M, Proulx F, et al. Ventilator-associated pneumonia in intubated children: comparison of different diagnostic methods. Pediatr Crit Care Med 2003;4: 437-43.
26. Zampoli MBM, Hsiao N, Whitelaw A, et al. Prevalence and outcome of cytomegalovirus-associated pneumonia in relation to human immunodeficiency virus infections. Pediatr Infect Dis J 2011;30: 413-17.
27. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21: 538-82.
28. Antoniadou A, Kontopidou F, Poulakou G, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007;59: 786-90.